Vaxcyte
PCVX
PCVX
198 hedge funds and large institutions have $3.9B invested in Vaxcyte in 2022 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 91 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
61% more call options, than puts
Call options by funds: $25.1M | Put options by funds: $15.6M
58% more funds holding
Funds holding: 125 → 198 (+73)
0.41% more ownership
Funds ownership: 102.87% → 103.28% (+0.41%)
Holders
198
Holding in Top 10
10
Calls
$25.1M
Puts
$15.6M
Top Buyers
| 1 | +$110M | |
| 2 | +$104M | |
| 3 | +$85.3M | |
| 4 |
BlackRock
New York
|
+$77.3M |
| 5 |
Jennison Associates
New York
|
+$68.2M |
Top Sellers
| 1 | -$149M | |
| 2 | -$103M | |
| 3 | -$100M | |
| 4 |
MVM
Medicxi Ventures Management
St. Helier,
Jersey
|
-$20.6M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$19.2M |